Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Long-term dystrophin restoration supports development of splice correction therapy for DMD patients with exon 2 duplications

Journal article

Roberts TC., (2023), Molecular Therapy Methods and Clinical Development, 31

EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method

Journal article

Hanson B. et al, (2023), Molecular Therapy - Nucleic Acids, 33, 511 - 528

Therapeutic approaches for Duchenne muscular dystrophy.

Journal article

Roberts TC. et al, (2023), Nat Rev Drug Discov

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.

Journal article

Forouhan M. et al, (2022), Acta Neuropathol, 143, 713 - 731

Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia

Journal article

Laitinen P. et al, (2022), PLoS ONE, 17

Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology


Martin Perez C. et al, (2022), Methods in Molecular Biology, 2383, 119 - 141

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Journal article

Hanson B. et al, (2021), RNA Biol, 1 - 15

Load More